Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors

被引:24
作者
Huber, HE
Robinson, RG
Watkins, A
Nahas, DD
Abrams, MT
Buser, CA
Lobell, RB
Patrick, D
Anthony, NJ
Dinsmore, CJ
Graham, SL
Hartman, GD
Lumma, WC
Williams, TM
Heimbrook, DC
机构
[1] Merck Res Labs, Dept Canc Res, West Point, PA 19486 USA
[2] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
关键词
D O I
10.1074/jbc.M100325200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have identified and characterized potent and specific inhibitors of geranylgeranyl-protein transferase type I (GGPTase I), as well as dual inhibitors of GGPTase I and farnesyl-protein transferase. Many of these inhibitors require the presence of phosphate anions for maximum activity against GGPTase I in vitro, Inhibitors with a strong anion dependence were competitive with geranylgeranyl pyrophosphate (GGPP), rather than with the peptide substrate, which had served as the original template for inhibitor design. One of the most effective anions was ATP, which at low millimolar concentrations increased the potency of GGPTase I inhibitors up to several hundred-fold. In the case of clinical candidate L-778,123, this increase in potency was shown to result from two major interactions: competitive binding of inhibitor and GGPP, and competitive binding of ATP and GGPP, At 5 mM, ATP caused an increase in the apparent K-d for the GGPP-GGPTase I interaction from 20 pM to 4 nM, resulting in correspondingly tighter inhibitor binding. A subset of very potent GGPP-competitive inhibitors displayed slow tight binding to GGPTase I with apparent on and off rates on the order of 10(6) M-1 s(-1) and 10(-3) s(-1) respectively, Slow binding and the anion requirement suggest that these inhibitors may act as transition state analogs. After accounting for anion requirement, slow binding, and mechanism of competition, the structure-activity relationship determined in vitro correlated well with the inhibition of processing of GGPTase I substrate Rap1a in vivo.
引用
收藏
页码:24457 / 24465
页数:9
相关论文
共 45 条
[1]   p21WAF1/CIP1 is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor β- and Sp1-responsive element:: Involvement of the small GTPase RhoA [J].
Adnane, J ;
Bizouarn, FA ;
Qian, YM ;
Hamilton, AD ;
Sebti, SM .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :6962-6970
[2]   Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules [J].
Ashar, HR ;
James, L ;
Gray, K ;
Carr, D ;
Black, S ;
Armstrong, L ;
Bishop, WR ;
Kirschmeier, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30451-30457
[3]   PHOTOREACTIVE ANALOGS OF PRENYL DIPHOSPHATES AS INHIBITORS AND PROBES OF HUMAN PROTEIN FARNESYLTRANSFERASE AND GERANYLGERANYLTRANSFERASE TYPE-I [J].
BUKHTIYAROV, YE ;
OMER, CA ;
ALLEN, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19035-19040
[4]  
COX AD, 1994, J BIOL CHEM, V269, P19203
[5]   A MECHANISM FOR POSTTRANSLATIONAL MODIFICATIONS OF PROTEINS BY YEAST PROTEIN FARNESYLTRANSFERASE [J].
DOLENCE, JM ;
POULTER, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :5008-5011
[6]   Yeast protein farnesyltransferase: Steady-state kinetic studies of substrate binding [J].
Dolence, JM ;
Cassidy, PB ;
Mathis, JR ;
Poulter, CD .
BIOCHEMISTRY, 1995, 34 (51) :16687-16694
[7]  
Du W, 1999, CANCER RES, V59, P5492
[8]   Therapeutic intervention and signaling [J].
Heimbrook, DC ;
Oliff, A .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) :284-288
[9]   Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state [J].
Huang, CC ;
Hightower, KE ;
Fierke, CA .
BIOCHEMISTRY, 2000, 39 (10) :2593-2602
[10]   Resistance of K-RasB(V12) proteins to farnesyltransferase inhibitors in Rat1 cells [J].
James, G ;
Goldstein, JL ;
Brown, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4454-4458